Oral Oncology

Papers
(The H4-Index of Oral Oncology is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Rare mandibular metastasis of Ewing sarcoma presenting as an endodontic infection96
Comment on “Circulating miRNAs as diagnostic biomarkers in HPV-associated oropharyngeal squamous cell carcinoma (OPSCC)”77
Commentary on, “Optimization of methylation capture sequencing workflow in formalin fixed tissue from oral squamous cell carcinoma patients”73
Commentary on, “Transoral endoscopic thyroidectomy vestibular approach for pT1b papillary thyroid carcinoma: Surgical and oncological outcomes.”48
Comment on “Extensive necrosis of the tongue as a very early adverse event of head and neck radiotherapy”43
Authors reply to the comment on: Association of sarcopenia with oncologic outcomes of primary treatment among patients with oral cavity cancer: A systematic review and meta-analysis40
Head and neck cancer with synchronous nodules of the lung as a diagnostic and therapeutic challenge – A systematic review38
Inter-assay reliability of programmed cell death-ligand 1 in head and neck squamous cell carcinoma38
Comments on the article titled “Factors associated with unknown primary status in head and neck squamous cell carcinoma”: Is the N status the overlooked elephant in the room?36
Illustrating potential actionable drug targets of head and neck tumors based on comprehensive genomic landscape of 386 samples35
Editorial Board/Aims & Scope34
Is 55 years an optimal age cutoff point for clinical staging in T1 papillary thyroid cancer?34
DNA Methylation Mediated Epigenetic Silencing of PD-1 and PD-L1: Therapeutic Implications in Oral Cancer34
“Haemophilia A” – Presenting with oral squamous cell carcinoma diagnosis and management strategies33
P28 Head and neck cancer cells differentiate resembling their tissue of origin32
Restoring the anti-tumor property of PTEN: A promising oral cancer treatment31
Radiation-induced osteosarcoma in the head and neck region: Case report and literature review31
Tumor subtype classification tool for HPV-associated head and neck cancers30
Comment on: “Feasibility and preliminary efficacy of a lymphedema and fibrosis self-management program for head and neck cancer survivors: A pilot randomized controlled trial”30
Division versus de-epithelialization of fibula osteocutaneous flap for composite oromandibular defects: A propensity score-matched analysis30
Letter to editor on “Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer”29
Letter to the editor, “Letter to the editor, “Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study.”29
Comment on: Predictors of recurrence, and the impact of adjuvant radiation therapy on survival in early stage (pT1–2, N0) oral cavity squamous cell carcinoma: A matched pair analysis28
What does margin mean in laryngeal surgery?28
Effective, efficient palliative radiotherapy for advanced head and neck cancer: Real world data using 25 Gy in 5 fractions28
Prognostic effect of surgical treatment in elderly oral squamous cell carcinoma patients: A retrospective study28
Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma26
Overestimated risk of transformation in oral lichen planus26
Radiation-induced sarcomas of the craniofacial region: A systematic review26
Required time for pre-oncological dental management – A rapid review of the literature26
Corrigendum to salivary microRNA- 375: A novel biomarker in the malignant transformation of oral potentially malignant disorders [Oral Oncol. 134 (2022) 106065]26
0.3310329914093